These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 30310855)

  • 1. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer stem cells and implications for future therapeutics.
    Wang J; Li ZH; White J; Zhang LB
    Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis.
    Zhu P; Lu T; Chen Z; Liu B; Fan D; Li C; Wu J; He L; Zhu X; Du Y; Tian Y; Fan Z
    Neuron; 2022 Jul; 110(14):2268-2282.e4. PubMed ID: 35550066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products targeting cancer stem cells: Implications for cancer chemoprevention and therapeutics.
    Gairola K; Gururani S; Bahuguna A; Garia V; Pujari R; Dubey SK
    J Food Biochem; 2021 Jul; 45(7):e13772. PubMed ID: 34028051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy.
    Papadaki S; Magklara A
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
    Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
    Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
    [No Abstract]   [Full Text] [Related]  

  • 15. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cancer stem cells and implications for future therapeutics.
    Qian X; Tan C; Wang F; Yang B; Ge Y; Guan Z; Cai J
    Onco Targets Ther; 2016; 9():2247-54. PubMed ID: 27143920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of liver cancer stem cells.
    Oishi N; Yamashita T; Kaneko S
    Liver Cancer; 2014 May; 3(2):71-84. PubMed ID: 24944998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
    Harrop R; O'Neill E; Stern PL
    Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.